Cardiac Wire

Home
Cardiac Wire

The fastest way to stay up-to-date on cardiology news.

16/01/2025

Hot off the press🔥
https://cardiacwire.com/newsletter/further-finerenone-findings-canarys-potential-obesity-cure/

The Finer Points of FINEARTS-HF
Can Canary Cure Obesity?
Kardigan’s Big Launch

Plus much more cardiology news!

Finerenone’s findings, Canary Cure’s obesity candidate, Kardigan’s big launch, and plenty of other cardiology news.

13/01/2025

Hot off the press🔥
https://cardiacwire.com/newsletter/ai-ccta-beats-spect-coffees-heart-benefits/

AI-CCTA Beats SPECT, Again
Coffee’s Cardioprotective Potential
Off-Label Guidelines

Plus much more cardiology news!

AI-CCTA beats SPECT, coffee’s heart benefits, off-label guidelines, and plenty of other cardiology news.

09/01/2025

Hot off the press🔥
https://cardiacwire.com/newsletter/ai-ecgs-strong-start-varipulses-stroke-scare/

AI-ECG’s 2025 Kickoff
J&J Halts VARIPULSE Eval
Aviation’s Cardiac Impact

Plus much more cardiology news!

AI-ECG’s rise, J&J halts VARIPULSE, aviation’s cardiac impact, and plenty of other cardiology news.

05/12/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/maritides-weight-loss-milestone-diabetes-early-impact/

MariTide’s Weight Loss Milestone
CVD & T2D
Pacemakers Placed, without Cardiologists

Plus much more cardiology news!

Amgen MariTide's solid data, T2D's early impact, and plenty of other cardiology news.

02/12/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/winrevair-wins-again-boards-are-big-business/

Winrevair’s Big PAH Win
Board Certification Is Big Business
Andexanet’s FDA Panel Uncertainties

Plus much more cardiology news!

Winrevair scores PAH win in ZENITH trial, board certification Is big business, and plenty of other cardiology news.

25/11/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/muvalaplin-aces-lpa-test-a-new-attr-cm-option/

Muvalaplin Aces Phase 2 Lp(a) Test
BridgeBio Lands ATTR-CM Approval
BridgeBio Adds Acoramidis Evidence

Plus much more cardiology news!

Lilly’s muvalaplin slashes Lp(a), NewAmsterdam’s drug combo cuts LDL-C, and plenty more cardiology news.

21/11/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/aha-2024-highlights-first-line-vt-ablation/

Ablation or Antiarrhythmics for Ventricular Tachycardia?
AI-ECHO Shows Us2.ai’s Promise
LAAC or Anticoagulants for AFib?

Plus much more cardiology news!

VANISH2 trial supports VT ablation, AI-ECHO shows Us2.ai’s promise, and plenty of other cardiology news.

18/11/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/tirzepatides-prediabetes-triumph-valvosoft-hits-endpoints/

Tirzepatide’s Prediabetes Triumph
Cardiawave Hits Valvosoft Endpoints
SmartCardia’s 7-Lead Clearance

Plus much more cardiology news!

Tirzepatide prediabetes win, Cardiawave hits Valvosoft endpoints, and plenty of other cardiology news.

14/11/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/the-safety-of-ivc-filters-ckm-cvd/

Forgotten IVC Filters Aren’t SAFE
CKM Syndrome Accelerates CVD
CVAUSA & ROMTech

Plus much more cardiology news!

An IVC filter removal problem, CKM syndrome accelerates CVD, and plenty of other cardiology news.

11/11/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/limflow-limits-clti-jjs-pfa-play/

LimFlow Limits Limb-Threatening Ischemia
J&J’s PFA Play
A Valve Access CAVEAT

Plus much more cardiology news!

LimFlow's 2-year benefits, J&J’s PFA gains FDA approval, and plenty of other cardiology news.

07/11/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/boston-scientific-bolsters-afib-mapping-hypertensions-digital-problem/

Boston Scientific Bolsters AFib Mapping with Cortex Acquisition
PHTI Digital Hypertension Problem
CVRx’s Outpatient Payment

Plus much more cardiology news!

Boston Scientific adds AFib mapping with Cortex acquisition, PHTI slams digital hypertension solutions, and plenty of other cardiology news.

04/11/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/tct-2024s-top-tavr-studies-cctas-big-day/

TCT 2024’s Top TAVR Studies
CCTA’s Reimbursement Boost
S1P’s AVD Potential

Plus much more cardiology news!

A TCT 2024 TAVR research review, CCTA’s big reimbursement boost, and plenty of other cardiology news.

23/09/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/2860/

Edgewise Therapeutics’ EDG-7500 Emerges as New HCM Contender
EU Recommends Wegovy for HF
Preventive LAAO

Plus much more cardiology news!

Edgewise's EDG-7500 shows HCM potential, a case for preventive LAAO, and plenty of other cardiology news.

19/09/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/questioning-pcis-lv-effect-an-ice-ai-alliance/

Questioning PCI’s Left Ventricular Dysfunction Effect
iCardio.ai & Abbott’s AI Alliance
DPP-4’s Mixed AS Impact

Plus much more cardiology news!

The case against PCI for LV dysfunction, iCardio.ai and Abbott’s AI alliance, and plenty more cardiology news.

16/09/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/americas-hypertension-problem-why-not-screen-for-afib/

America’s Hypertension Awareness and Control Problem
Thumbs Down for Mass AFib Screening
Mixed Wearable AF Screening Results

Plus much more cardiology news!

America's hypertension control problem, AFib screening misses its mark, and plenty of other cardiology news.

05/09/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/asundexians-oceanic-setback-esc-2024-highlights/

Burn the Ships? What OCEANIC-AF Means for Asundexian and Factor XI
PVI Is No Sham
Kerendia Cuts HF Events, CV Mortality

Plus much more cardiology news!

Why Bayer halted its asundexian trial, the best of ESC 2024, and plenty of other cardiology news.

03/09/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/vutrisiran-shines-hypertension-paradigm-shift/

Alylam’s Vutrisiran Shines in HELIOS-B Trial
2024 ESC Hypertension Guidelines
DynamX’s Real World Advantages

Plus much more cardiology news!

Alylam’s vutrisiran shows ATTR-CM potential, stricter hypertension guidelines, and plenty of other cardiology news.

29/08/2024

Hot off the press🔥
https://cardiacwire.com/newsletter/leqvio-monotherapy-tcm-for-arrhythmia/

Novartis Leqvio’s Case for Broader ASCVD Prevention
TCM’s Arrhythmia Impact
Wegovy’s Massive Medicare Costs

Plus much more cardiology news!

Leqvio monotherapy evidence, traditional Chinese medicine treats arrhythmia, Wegovy’s massive Medicare costs, and plenty of other cardiology news.

Address

Website

http://cardiacwire.com/

Alerts

Be the first to know and let us send you an email when Cardiac Wire posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cardiac Wire:

Shortcuts

Address
Alerts
Contact The Business
Claim ownership or report listing
Want your business to be the top-listed Media Company?

Country:

City: